Shares of Biogen and other drugmakers researching Alzheimer’s disease soared early Wednesday after Japan’s Eisai Co. said its potential treatment appeared to slow the fatal disease’s progress in a late-stage study
Related posts
-
County board to consider speed reduction on Lake in the Hills road
Drivers on Pyott Road in Lake in the Hills might soon be required to slow down... -
Census estimates show suburbs rebounding from previous population declines
After years of steady population declines, the U.S. Census Bureau’s latest estimates show most suburbs regaining... -
AG: Tollway violated the Open Meetings Act with settlement vote
The Illinois tollway “fully accepts the findings and recommendations regarding a one-time oversight.” But, those actions...